Forward Citations = 175

Loading Chart...

4 inventors (with patents filed for the assignee):

Jennifer A Doudna (20 out of 145 patents)

Martin Jinek (20 out of 66 patents)

Krzysztof Chylinski (20 out of 62 patents)

4. Emmanuelle Charpentier (20 out of 61 patents)

20 patents: Sort by Forward Citations

1. 11549127 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2023-01-10),

2. 11186849 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-11-30),

3. 11008590 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-05-18),

4. 11001863 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-05-11),

5. 10988782 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-04-27),

6. 10982231 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-04-20),

7. 10982230 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-04-20),

8. 10900054 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-01-26),

9. 10612045 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-04-07),

10. 10570419 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-02-25),

11. 10563227 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-02-18),

12. 10533190 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-01-14),

13. 10526619 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-01-07),

14. 10428352 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2019-10-01),

15. 10385360 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2019-08-20),

Company Overview

Emmanuelle Charpentier is a prominent figure in the field of molecular biology and genetics, known for her pioneering work in CRISPR technology. Based in Braunschweig, Germany, her research focuses on genome editing and the development of innovative biotechnological applications. Charpentier's contributions have significantly advanced our understanding of gene regulation and have opened new avenues for therapeutic interventions in various diseases, positioning her at the forefront of genetic research and biotechnology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

20 Patents

#9 in Braunschweig

#2,216 in Germany

#31,233 in the World

Braunschweig, Germany

Emmanuelle Charpentier

Forward Citations = 175

4 inventors:

Jennifer A Doudna (20 out of 145 patents)

Martin Jinek (20 out of 66 patents)

Krzysztof Chylinski (20 out of 62 patents)

4. Emmanuelle Charpentier (20 out of 61 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emmanuelle Charpentier. Retrieved from https://idiyas.com/company/emmanuelle-charpentier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]